Skip to main content
. 2022 Nov 21;75(Suppl 4):S562–S570. doi: 10.1093/cid/ciac754

Figure 1.

Figure 1.

Graphical summary of the major pharmacokinetic processes determining the disposition of mAbs and their modulation in newborns and infants. The gear symbol indicates elimination processes. Figure from Z. Temrikar et al Paediatr Drugs 2020 [22]. Abbreviations: ADA, anti-drug antibody; FcRn, neonatal Fc receptor; Ig, immunoglobulin; IM, intramuscular; IV, intravenous; mAb, monoclonal antibody; SC, subcutaneous.